The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 18, 2016
Filed:
Sep. 22, 2011
Applicants:
David Boothman, Austin, TX (US);
Jinming Gao, Plano, TX (US);
Erik Bey, Austin, TX (US);
Ying Dong, Austin, TX (US);
Inventors:
David Boothman, Austin, TX (US);
Jinming Gao, Plano, TX (US);
Erik Bey, Austin, TX (US);
Ying Dong, Austin, TX (US);
Assignee:
The Board of Regents of the University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C12Q 1/68 (2006.01); A61K 31/00 (2006.01); A61K 31/352 (2006.01); A61K 31/357 (2006.01); A61K 31/4025 (2006.01); A61K 31/423 (2006.01); A61K 31/538 (2006.01); A61K 45/06 (2006.01); A61N 5/10 (2006.01); C12Q 1/26 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/00 (2013.01); A61K 31/352 (2013.01); A61K 31/357 (2013.01); A61K 31/4025 (2013.01); A61K 31/423 (2013.01); A61K 31/538 (2013.01); A61K 45/06 (2013.01); A61N 5/10 (2013.01); C12Q 1/26 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01);
Abstract
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.